Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELAFIBRANOR for Primary biliary cholangitis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 288 adverse event reports in the FDA FAERS database where ELAFIBRANOR was used for Primary biliary cholangitis.

Most Reported Side Effects for ELAFIBRANOR

Side Effect Reports % Deaths Hosp.
Fatigue 45 12.6% 0 1
Pruritus 34 9.6% 0 0
Constipation 33 9.3% 0 2
Nausea 30 8.4% 0 1
Product dose omission issue 27 7.6% 1 5
Weight increased 26 7.3% 0 0
Myalgia 25 7.0% 0 0
Diarrhoea 24 6.7% 0 3
Arthralgia 21 5.9% 0 0
Dizziness 17 4.8% 1 2
Muscle spasms 16 4.5% 0 0
Headache 15 4.2% 0 0
Vomiting 15 4.2% 0 1
Abdominal distension 13 3.7% 0 0
Abdominal pain 13 3.7% 0 0

Other Indications for ELAFIBRANOR

Product used for unknown indication (57) Off label use (10)

Other Drugs Used for Primary biliary cholangitis

OBETICHOLIC ACID (4,838) URSODIOL (203) FENOFIBRATE (40) SELADELPAR LYSINE (39) SELADELPAR (36) AZATHIOPRINE (14) BEZAFIBRATE (13) PREDNISONE (11) RITUXIMAB (11) BUDESONIDE (8)

Related Pages

ELAFIBRANOR Full Profile All Primary biliary cholangitis Drugs ELAFIBRANOR Demographics ELAFIBRANOR Timeline